|
1
|
Guo LW, Huang HY, Shi JF, Lv LH, Bai YN,
Mao AY, Liao XZ, Liu GX, Ren JS, Sun XJ, et al: Medical expenditure
for esophageal cancer in China: A 10-year multicenter retrospective
survey (2002-2011). Chin J Cancer. 36(73)2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jiang C, Li X, Zhao H and Liu H: Long
non-coding RANs: Potential new biomarkers for predicting tumor and
metastasis. Mol Cancer. 15(62)2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Seles M, Hutterer GC, Kiesslich T, Pummer
K, Berindan-Neagoe I, Perakis S, Schwarzenbacher D, Stotz M, Gerger
A and Pichler M: Current insights into long non-coding RNAs in
renal cell carcinoma. Int J Mol Sci. 17(573)2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Feil R, Walter J, Allen ND and Reik W:
Developmental control of allelic methylation in the imprinted mouse
Igf2 and H19 genes. Development. 120:2933–2943. 1994.PubMed/NCBI
|
|
6
|
Raveh E, Matouk IJ, Gilon M and Hochberg
A: The H19 long non-coding RNA in cancer initiation, progression
and metastasis-a proposed unifying theory. Mol Cancer.
14(184)2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Zhang X, Zhou Y, Mehta KR, Danila DC,
Scolavino S, Johnson SR and Klibanski A: A pituitary-derived MEG3
isoform functions as a growth suppressor in tumor cells. J Clin
Endocrinol Metab. 88:5119–5126. 2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhou Y, Zhang X and Klibanski A: MEG3
noncoding RNA: A tumor suppressor. J Mol Endocrinol. 48:R45–R53.
2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Ip JY, Sone M, Nashiki C, Pan Q, Kitaichi
K, Yanaka K, Abe T, Takao K, Miyakawa T, Blencowe BJ and Nakagawa
S: Gomafu lncRNA knockout mice exhibit mild hyperactivity with
enhanced responsiveness to the psychostimulant methamphetamine. Sci
Rep. 6(27204)2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lai IL, Yang CA, Lin PC, Chan WL, Lee YT,
Yen JC, Chang YS and Chang JG: Long noncoding RNA MIAT promotes
non-small cell lung cancer proliferation and metastasis through
MMP9 activation. Oncotarget. 8:98148–98162. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sha M, Lin M, Wang J, Ye J, Xu J, Xu N and
Huang J: Long non-coding RNA MIAT promotes gastric cancer growth
and metastasis through regulation of miR-141/DDX5 pathway. J Exp
Clin Cancer Res. 37(58)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li Y, Wang K, Wei Y, Yao Q, Zhang Q, Qu H
and Zhu G: lncRNA-MIAT regulates cell biological behaviors in
gastric cancer through a mechanism involving the miR-29a-3p/HDAC4
axis. Oncol Rep. 38:3465–3472. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Liu Z, Wang H, Cai H, Hong Y, Li Y, Su D
and Fan Z: Long non-coding RNA MIAT promotes growth and metastasis
of colorectal cancer cells through regulation of miR-132/Derlin-1
pathway. Cancer Cell Int. 18(59)2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xiang Y, Huang Y, Sun H, Pan Y, Wu M and
Zhang J: Deregulation of miR-520d-3p promotes hepatocellular
carcinoma development via lncRNA MIAT regulation and EPHA2
signaling activation. Biomed Pharmacother. 109:1630–1639.
2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Huang X, Gao Y, Qin J and Lu S: lncRNA
MIAT promotes proliferation and invasion of HCC cells via sponging
miR-214. Am J Physiol Gastrointest Liver Physiol. 314:G559–G565.
2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Rinn JL, Kertesz M, Wang JK, Squazzo SL,
Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E and
Chang HY: Functional demarcation of active and silent chromatin
domains in human HOX loci by noncoding RNAs. Cell. 129:1311–1323.
2007.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Takahashi Y, Sawada G, Kurashige J, Uchi
R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, et
al: Amplification of PVT-1 is involved in poor prognosis via
apoptosis inhibition in colorectal cancers. Br J Cancer.
110:164–171. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ishii N, Ozaki K, Sato H, Mizuno H, Saito
S, Takahashi A, Miyamoto Y, Ikegawa S, Kamatani N, Hori M, et al:
Identification of a novel non-coding RNA, MIAT, that confers risk
of myocardial infarction. J Hum Genet. 51:1087–1099.
2006.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou L, Xu DY, Sha WG, Shen L, Lu GY and
Yin X: Long non-coding MIAT mediates high glucose-induced renal
tubular epithelial injury. Biochem Biophys Res Commun. 468:726–732.
2015.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shen Y, Dong LF, Zhou RM, Yao J, Song YC,
Yang H, Jiang Q and Yan B: Role of long non-coding RNA MIAT in
proliferation, apoptosis and migration of lens epithelial cells: A
clinical and in vitro study. J Cell Mol Med. 20:537–548.
2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Takeda S, Liu H, Sasagawa S, Dong Y,
Trainor PA, Cheng EH and Hsieh JJ: HGF-MET signals via the MLL-ETS2
complex in hepatocellular carcinoma. J Clin Invest. 123:3154–3165.
2013.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
Robert I, Aussems M, Keutgens A, Zhang X,
Hennuy B, Viatour P, Vanstraelen G, Merville MP, Chapelle JP, de
Leval L, et al: Matrix Metalloproteinase-9 gene induction by a
truncated oncogenic NF-kappaB2 protein involves the recruitment of
MLL1 and MLL2 H3K4 histone methyltransferase complexes. Oncogene.
28:1626–1638. 2009.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Almeida-Rios D, Graça I, Vieira FQ,
Ramalho-Carvalho J, Pereira-Silva E, Martins AT, Oliveira J,
Gonçalves CS, Costa BM, Henrique R and Jerónimo C: Histone
methyltransferase PRMT6 plays an oncogenic role of in prostate
cancer. Oncotarget. 7:53018–53028. 2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Shay G, Lynch CC and Fingleton B: Moving
targets: Emerging roles for MMPs in cancer progression and
metastasis. Matrix Biol. 44-46:200–206. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang X and Khalil RA: Matrix
metalloproteinases, vascular remodeling, and vascular disease. Adv
Pharmacol. 81:241–330. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Wang G, Yin L, Peng Y, Gao Y, Gao H, Zhang
J, Lv N, Miao Y and Lu Z: Insulin promotes invasion and migration
of KRASG12D mutant HPNE cells by upregulating MMP-2
gelatinolytic activity via ERK- and PI3K-dependent signalling. Cell
Prolif. 52(e12575)2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhu W, Wu X, Yang B, Yao X, Cui X, Xu P
and Chen X: miR-188-5p regulates proliferation and invasion via
PI3K/Akt/MMP-2/9 signaling in keloids. Acta Biochim Biophys Sin
(Shanghai). 51:185–196. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Zong L, Wei X, Gou W, Huang P and Lv Y:
Zinc improves learning and memory abilities of fetal growth
restriction rats and promotes trophoblast cell invasion and
migration via enhancing STAT3-MMP-2/9 axis activity. Oncotarget.
8:115190–115201. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Zhang W, Yin L, Song G, Han X, Yin Z and
Luo D: LKB1 loss cooperating with BRAF V600E promotes melanoma cell
invasion and migration by up-regulation MMP-2 via PI3K/Akt/mTOR
pathway. Oncotarget. 8:113847–113857. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Beales ILP, Garcia-Morales C, Ogunwobi OO
and Mutungi G: Adiponectin inhibits leptin-induced oncogenic
signalling in oesophageal cancer cells by activation of PTP1B. Mol
Cell Endocrinol. 382:150–158. 2014.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Allott EH, Lysaght J, Cathcart MC, Donohoe
CL, Cummins R, McGarrigle SA, Kay E, Reynolds JV and Pidgeon GP:
MMP9 expression in oesophageal adenocarcinoma is upregulated with
visceral obesity and is associated with poor tumour
differentiation. Mol Carcinog. 52:144–154. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Gonzales AJ, Goldsworthy TL and Fox TR:
Chemical transformation of mouse liver cells results in altered
cyclin D-CDK protein complexes. Carcinogenesis. 19:1093–1102.
1998.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Kokkinakis DM, Liu X and Neuner RD:
Modulation of cell cycle and gene expression in pancreatic tumor
cell lines by methionine deprivation (methionine stress):
Implications to the therapy of pancreatic adenocarcinoma. Mol
Cancer Ther. 4:1338–1348. 2005.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Chan KC, Wang CJ, Ho HH, Chen HM and Huang
CN: Simvastatin inhibits cell cycle progression in
glucose-stimulated proliferation of sortic vascular smooth cells by
up-regulating cyclin dependent kinase inhibitors and p53. Pharmacol
Res. 58:247–256. 2008.PubMed/NCBI View Article : Google Scholar
|
